Through this large scale functional screening, we identified Furin as a novel potential target that shows a synthetic lethal interaction with c-Myc in c-Myc-driven ovarian cancers, and demonstrated that genetic and pharmacological inhibition of Furin led to growth inhibition of c-Myc-driven ovarian cancer cells. The gene discussed is MYC; the disease is ovarian carcinoma.